Screener
Vera Therapeutics VERA Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Vera Therapeutics’s reported figures.
The source filing: Vera Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212143
FAQ
- What is Vera Therapeutics's invested capital?
- Vera Therapeutics (VERA) reported invested capital of $460.38M in Q1 2026.
- How has Vera Therapeutics's invested capital changed year-over-year?
- Vera Therapeutics's invested capital decreased by 13.8% year-over-year, from $534.37M to $460.38M.
- What is the long-term trend for Vera Therapeutics's invested capital?
- Over 4 years (2021 to 2025), Vera Therapeutics's invested capital has grown at a 221.9% compound annual growth rate (CAGR), from $3.05M to $327.1M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Vera Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude